VOYA Investment Management
XENE icon

VOYA Investment Management’s Xenon Pharmaceuticals XENE Stock Holding History

VOYA Investment Management’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.66M Buy
77,245
+8,882
+13% +$493K ﹤0.01% 894
2026
Q1 		$3.98M Buy
68,363
+7,505
+12% +$346K ﹤0.01% 923
2025
Q4 		$2.73M Hold
60,858
– – ﹤0.01% 1091
2025
Q3 		$2.44M Buy
60,858
+1,393
+2% +$49.1K ﹤0.01% 1150
2025
Q2 		$1.86M Buy
59,465
+11,400
+24% +$372K ﹤0.01% 1336
2025
Q1 		$1.61M Sell
48,065
-14,350
-23% -$545K ﹤0.01% 1389
2024
Q4 		$2.45M Buy
62,415
+15,250
+32% +$631K ﹤0.01% 1230
2024
Q3 		$1.86M Hold
47,165
– – ﹤0.01% 1361
2024
Q2 		$1.84M Sell
47,165
-17,775
-27% -$711K ﹤0.01% 1341
2024
Q1 		$2.8M Hold
64,940
– – ﹤0.01% 1212
2023
Q4 		$2.99M Sell
64,940
-2,200
-3% -$77.7K ﹤0.01% 1202
2023
Q3 		$2.29M Hold
67,140
– – ﹤0.01% 1278
2023
Q2 		$2.58M Hold
67,140
– – ﹤0.01% 1245
2023
Q1 		$2.4M Hold
67,140
– – ﹤0.01% 1280
2022
Q4 		$2.65M Hold
67,140
– – ﹤0.01% 1229
2022
Q3 		$2.42M Buy
+67,140
New +$2.41M ﹤0.01% 1242

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

VOYA Investment Management's XENE Position: Q2 2026 in Review

VOYA Investment Management increased its Xenon Pharmaceuticals (XENE) stake by 13% in Q2 2026, buying an estimated $493K and bringing the position to 77,245 shares worth $4.66M. The position accounts for ﹤0.01% of the portfolio, ranked #894.

VOYA Investment Management first reported a position in XENE in Q3 2022 and has held it in 16 quarters since. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • VOYA Investment Management held 77,245 shares of Xenon Pharmaceuticals worth $4.66M as of Q2 2026.
  • VOYA Investment Management bought 8,882 Xenon Pharmaceuticals shares in Q2 2026, an estimated $493K.
  • Xenon Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #894 holding.
  • VOYA Investment Management first reported a position in Xenon Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • 315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.